AATS: American Association for Thoracic Surgery.
Watch the AATS Leadership Video
 
Preliminary Program Outline
Back to Annual Meeting Program
< 2010 Program Index

Annual Meeting
eGuide

SUNDAY, MAY 2, 2010
8:00 a.m. - 5:00 p.m.   AATS/STS ADULT CARDIAC SURGERY SYMPOSIUM
Hall C, Metro Toronto Convention Centre

Chair:
Marc R. Moon, MD
Washington University School of Medicine

COURSE OBJECTIVES
At the conclusion of this course, the participants will be able to:
• Determine which patients with bicuspid aortic valve disease will require simultaneous ascending aortic replacement, how much of the aortic will need to be resected and the specific surgical techniques necessary to safely perform the procedure.
• Differentiate single leaflet versus bileaflet prolapse and learn surgical skills necessary to repair both varieties successfully.
• Assess patient subgroups who would be served best by coronary bypass grafting versus a percutaneous intervention.
• Identify patients a priori in whom it may not be cost conscious or appropriate from a quality of life standpoint to implant a left ventricular assist device or repair a thoracoabdominal aneurysm.
    Session I
Bicuspid Aortic Valve Disease
 
8:00 a.m. – 8:15 a.m.   Pathobiology and Genetics of Bicuspid Aortopathy
Joseph C. Schmoker, MD
University of Vermont
8:15 a.m. – 8:30 a.m.   When to Replace the Ascending Aorta in Bicuspid Disease
Michael A. Borger, MD
University of Leipzig
8:30 a.m. – 8:45 a.m.   Aortic Replacement in Bicuspid Disease:
How to Match the Procedure to the Patient
John S. Ikonomidis, MD, PhD
Medical University of South Carolina
8:45 a.m. – 9:05 a.m.   How I Do It: Bicuspid Valve-Sparing Root Replacement “Skin-to-Skin”
D. Craig Miller, MD
Stanford University
9:05 a.m. – 9:20 a.m.   DISCUSSION
    Session II
Barlow’s Syndrome and Atrial Fibrillation
 
9:20 a.m. – 9:40 a.m.   Leonardo Da Vinci and the Mitral Valve
Francis C. Wells, FRCS
Papworth Hospital
9:40 a.m. – 9:55 a.m.   Barlow’s Syndrome: Simple Bileaflet Prolapse or More?
Clifford W. Barlow, MD
Southampton General Hospital
9:55 a.m. – 10:15 a.m.   BREAK
10:15 a.m. – 10:35 a.m.   How I Do It: Repair a Barlow’s Valve “Skin-to-Skin”
Tirone E. David, MD
Toronto General Hospital
10:35 a.m. – 10:50 a.m.   Mitral Regurgitation with Paroxysmal Atrial Fibrillation:
Is Concomitant Surgical Ablation Always Required?
Ralph J. Damiano, Jr., MD
Washington University School of Medicine
10:50 a.m. – 11:05 a.m.   Surgical Ablation: Which Lesion Set for Which Patient?
Patrick M. McCarthy, MD
Northwestern University
11:05 a.m. – 11:20 a.m.   DISCUSSION
    Session III
Malpractice in Cardiac Surgery – Debate
 
11:20 a.m. – 11:50 a.m.   Malpractice in Cardiac Surgery is the End-Result of: “Bad” Doctors
G. Randall Green, MD, JD
St. Joseph’s Hospital

Malpractice in Cardiac Surgery is the End-Result of: “Bad” Lawyers
Abe DeAnda, Jr., MD
Montefiore/Albert Einstein College of Medicine
11:50 a.m. – 1:15 p.m.  

LUNCHEON SYMPOSIUM A
Hall C, Metro Toronto Convention Centre

How I Do It: Robotic Mitral Valve Repair “Skin-to-Skin”
W. Randolph Chitwood, Jr., MD
East Carolina University

LUNCHEON SYMPOSIUM B
Constitution 107, Metro Toronto Convention Centre

CABG in 2010: Lessons from the Syntax Trial
Michael J. Mack, MD
CT Surgery Associates of North Texas

David Paul Taggart, MD, PhD
University of Oxford

  Session IV
Transcatheter Valve Repair and Replacement
 
1:15 p.m. – 1:30 p.m.   Clinical Update: When Will Transcatheter Aortic Valve Replacement Be Available in Anytown, USA?
Alan Zajarias, MD
Washington University School of Medicine
1:30 p.m. – 1:45 p.m.   How I Do It: Transfemoral / Transapical AVR
Todd M. Dewey, MD
Medical City Dallas Hospital
1:45 p.m. – 2:05 p.m.   How I Do It: Minimally-Invasive AVR “Skin-to-Skin”
Lawrence H. Cohn, MD
Brigham & Women's Hospital
2:05 p.m. – 2:20 p.m.   Percutaneous Mitral Valve Repair: Reality, Dream or Nightmare?
Michael J. Mack, MD
CT Surgery Associates of North Texas
2:20 p.m. – 2:35 p.m. DISCUSSION
2:35 p.m. – 2:45 p.m. With Regard to Afflictions of the Heart, Are Men and Women Created Equal?
Jennifer S. Lawton, MD
Washington University School of Medicine
    Session V
“When Not To” in Cardiac Surgery
 
2:45 p.m. – 3:00 p.m.   When Not To: Use the Radial Artery
Hendrick B. Barner, MD
Saint Louis University
3:00 p.m. – 3:15 p.m.   When Not To: Use Bilateral (or Unilateral) Mammary Arteries
Bruce W. Lytle, MD
Cleveland Clinic Foundation 
3:15 p.m. – 3:35 p.m.   BREAK
3:35 p.m. – 3:50 p.m.   When Not To: Do a Ross Procedure
Nicholas T. Kouchoukos, MD
Missouri Baptist Medical Center
3:50 p.m. – 4:05 p.m.   When Not To: Implant an LVAD at “End-of-Life”
Nicholas G. Smedira, MD
Cleveland Clinic Foundation 
4:05 p.m. – 4:20 p.m.   When Not To: Replace a “Large” Thoracoabdominal Aneurysm
Thoralf M. Sundt, III, MD
Mayo Clinic
4:20 p.m. – 4:35 p.m.   When Not To: Do an Off-Pump CABG
Craig R. Smith, MD
Columbia University
4:35 p.m. – 4:50 p.m.   When Not To: Repair Ischemic Mitral Regurgitation
Irving L. Kron, MD
University of Virginia
4:50 p.m. – 5:00 p.m.   DISCUSSION
5:00 p.m.   ADJOURN TO WELCOME RECEPTION
Exhibit Hall A & B
 
8:00 a.m. - 5:00 p.m.   AATS/STS GENERAL THORACIC SURGERY SYMPOSIUM
Constitution 106, Metro Toronto Convention Centre

Chair:
Bryan F. Meyers, MD, MPH
Washington University School of Medicine

COURSE OBJECTIVES
At the conclusion of this course, the participants will be able to:
• Outline the ideal preoperative evaluation for a patient referred for surgery for GERD.
• Develop an ideal surgical plan for a giant paraesophageal hernia.
• Describe the pros and cons of the surgical alternatives for the redo hiatal hernia.
• Discuss the risks, benefits and costs of crural buttressing for paraesophageal hernia repair.
• Relate the key elements needed to start a pulmonary thromboendarterectomy program.
8:00 a.m. – 8:10 a.m.   Introduction and Course Overview
Bryan F. Meyers, MD, MPH
Washington University School of Medicine
    Session I
Benign Esophageal Disease
 
8:10 a.m. – 8:35 a.m.   Modern Evaluation of the GERD Patient for Surgery
Thomas J. Watson, MD
University of Rochester
8:35 a.m. – 9:00 a.m.   Primary Surgical Approach for Giant PEH
Gail E. Darling, MD
University of Toronto
9:00 a.m. – 9:25 a.m.   Multiple Redo Hernia Surgery: Open or Resection?
Andrew C. Chang, MD
University of Michigan Health System
9:25 a.m. – 9:50 a.m.   Crural Buttressing: When, Why and with What Material?
Michael A. Maddaus, MD
University of Minnesota Hospital
9:50 a.m. – 10:05 a.m.   DISCUSSION
10:05 a.m. – 10:35 a.m.   BREAK
    Session II
Lung Failure and Transplantation
 
10:35 a.m. – 11:00 a.m.   Building a Pulmonary Thromboendarterectomy Program
Marc de Perrot, MD, MSc
Toronto General Hospital / Princess Margaret Hospital
11:00 a.m. – 11:25 a.m.   Bilateral versus Single Lung Transplantation
David Park Mason, MD
Cleveland Clinic Foundation 
11:25 a.m. – 11:50 a.m.   Experience with Living Donor Lung Transplantation
Hiroshi Date, MD
Kyoto University
11:50 a.m. – 12:00 p.m.   DISCUSSION
12:00 p.m. – 1:30 p.m.   LUNCHEON SYMPOSIUM
Constitution 106, Metro Toronto Convention Centre

Tracheal Reconstruction with Tissue Engineered Airway
Paolo Macchiarini, MD, PhD
Hospital Clinico de Barcelona
    Session III
Esophageal Cancer
 
1:30 p.m. – 1:50 p.m.   Optimal Staging of the Patient with Esophageal Cancer
Stephen D. Cassivi, MD, MSc
Mayo Clinic
1:50 p.m. – 2:10 p.m.   Selection of Patients for and Outcomes of Induction Therapy
Richard J. Battafarano, MD, PhD
University of Maryland
2:10 p.m. – 2:30 p.m.   Fast-tracking the Esophagectomy Patient
Henning A. Gaissert, MD
Massachusetts General Hospital
2:30 p.m. – 2:50 p.m.   Approach and Anastomotic Techniques for Esophagectomy
Ara A. Vaporciyan, MD
MD Anderson Cancer Center
2:50 p.m. – 3:20 p.m.   DISCUSSION
3:20 p.m. – 3:50 p.m.   BREAK
    Session IV
Mediastinal Diseases
 
3:50 p.m. – 4:10 p.m.   Transcervical Extended Mediastinal Lymphadenectomy
Marcin Zielinski, MD
Pulmonary Hospital
4:10 p.m. – 4:30 p.m.   Eliminating Stump Leaks After Right Pneumonectomy
Kenneth A. Kesler, MD
Indiana University
4:30 p.m. – 5:00 p.m.   DISCUSSION
5:00 p.m.   ADJOURN TO WELCOME RECEPTION
Exhibit Hall A & B
 
7:55 a.m. - 5:00 p.m.   AATS/STS CONGENITAL HEART DISEASE SYMPOSIUM
Constitution 105, Metro Toronto Convention Centre

Chair:
Charles B. Huddleston, MD
St. Louis Children’s Hospital

COURSE OBJECTIVES
At the conclusion of this course, the participants will be able to:
• Implement new monitoring techniques for critical care.
• Apply indications and new therapies for treating pulmonary valve insufficiency.
• Discuss the advantages/disadvantages of different techniques for the Fontan procedure.
• Demonstrate best technique for repair of AV valve regurgitation in single ventricle patients, repair of supravalvar AS, repair of AP window, transplantation following failed Fontan.
7:55 a.m. - 8:00 a.m.   Introduction
Charles B. Huddleston, MD
St. Louis Children’s Hospital
8:00 a.m. – 8:40 a.m.   Extra-Cardiac versus Intra-Atrial Lateral Tunnel Fontan

Extra-Cardiac is Better
Carl L. Backer, MD
Children’s Memorial Hospital

No, it’s Not
Richard A. Jonas, MD
Children’s National Medical Center
8:40 a.m. – 8:45 a.m.   DISCUSSION
8:45 a.m. – 9:25 a.m.   Adults with CHD

PVR Following Repair of TOF – Now When?
Candice K. Silversides, MD
Toronto General Hospital

Catheter-Based PVR – Where Does this Stand?
Lee N. Benson, MD
Hospital for Sick Children
9:25 a.m. – 9:35 a.m.   DISCUSSION
9:35 a.m. – 10:15 a.m.   Impact of Fetal Intervention on Neonatal Congenital Heart Surgery
Emile A. Bacha, MD
New York Children’s Hospital
10:15 a.m. – 10:45 a.m.   BREAK
    Mechanical Support Talks
10:45 a.m. – 11:00 a.m.   Mechanical Cardiac Support for Infants
Charles D. Fraser, MD
Texas Children’s Hospital
11:00 a.m. – 11:15 a.m.   Expanding Options in Extracorporeal Lung Support
Shaf Keshavjee, MD, MSc
Toronto General Hospital
11:15 a.m. – 11:30 a.m.   Venous ‘assist’ for Fontan/Glenn
Mark D. Rodefeld, MD
Indiana University School of Medicine
11:30 a.m. – 12:00 p.m.   DISCUSSION
12:00 p.m.   LUNCHEON SYMPOSIUM
Constitution 105, Metro Toronto Convention Centre

Objective Assessment of Cardiac Output in Infants Following Cardiac Surgery
Desmond Bohn, MD
The Hospital for Sick Children
1:30 p.m. – 1:45 p.m.   AVVR in Single Ventricle
Glen S. Van Arsdell, MD
The Hospital for Sick Children
1:45 p.m. – 2:00 p.m.   Supravalvar AS in Infants
Max B. Mitchell, MD
The Children’s Hospital Heart Institute
2:00 p.m. – 2:15 p.m.   AP Window and Associated Anomalies
James S. Tweddell, MD
Medical College of Wisconsin
2:15 p.m. – 2:30 p.m.   Heart Transplantation for Failed Fontan
Ralph S. Mosca, MD
NYU Langone Medical Center
2:30 p.m. – 2:40 p.m.   DISCUSSION
2:40 p.m. – 3:00 p.m.   BREAK
    Worst Case Scenarios
3:00 p.m. – 3:20 p.m.   Constantine Mavroudis, MD
Cleveland Clinic
3:20 p.m. – 3:40 p.m.   Kirk R. Kanter, MD
Emory University School of Medicine
3:40 p.m. – 4:00 p.m.   DISCUSSION
4:00 p.m. – 5:00 p.m.   Historical Talks
4:00 p.m. – 4:25 p.m. Norwood Procedure – How it Started
William I. Norwood, Jr., MD. PhD
4:25 p.m. – 4:50 p.m. TX for HLHS – How it Started
Leonard L. Bailey, MD
Loma Linda University Medical Center
4:50 p.m. – 5:00 p.m. DISCUSSION
5:00 p.m.   ADJOURN TO WELCOME RECEPTION
Exhibit Hall A & B
 
8:00 a.m. - 5:00 p.m. AATS/STS CARDIOTHORACIC CRITICAL CARE SYMPOSIUM NEW in 2010
Room 201, Metro Toronto Convention Centre

Chairs:
Nevin M. Katz
Washington Institute of Thoracic & CV Surgery

Michael S. Mulligan
University of Washington Medical Center

COURSE OBJECTIVES
At the conclusion of this course, the participants will be able to:
• Understand unique specialty aspects of Cardiovascular-Thoracic (CVT) Critical Care including ECMO and mechanical circularity support.
• Integrate nutritional innovations into the practice of CVT Critical Care.
• Apply evidence-based blood and component transfusion guidelines to clinical practice.
• Select appropriate anti-microbial agents and practices for treatment and prevention of nosocomial infection including CVL nfections.
8:00 a.m. – 8:05 a.m.   Welcome and Opening Remarks
Michael S. Mulligan, MD
University of Washington Medical Center
8:05 a.m. – 8:30 a.m.   Evolution of CTS Critical Care: Systems Based Management, Training and Certification Implications
Nevin M. Katz, MD
Washington Institute of Thoracic & CV Surgery
8:30 a.m. – 8:55 a.m.   Sedation in the ICU Patient
Brian J. Woodcock, MD
University of Michigan Health System
8:55 a.m. – 9:20 a.m.   ECMO Support for the Failing Heart/Lung
Jonathan W. Haft, MD
University of Michigan
9:20 a.m. – 9:45 a.m.   Arrhythmia Management
Ralph Damiano, Jr., MD
Washington University School of Medicine
9:45 a.m. – 10:00 a.m.   BREAK
10:00 a.m. – 10:25 a.m.   Advanced Ventilator Management (Low Stretch Ventilation and Permissive Hypercapnea)
Leonard D. Hudson, MD
University of Washington Medical Center
10:25 a.m. – 10:50 a.m.   LVAD and Mechanical Support Post-operative Care
Francis D. Pagani, MD
University of Michigan Health System
10:50 a.m. – 11:15 a.m.   Lung Transplant Perioperative Care
Michael S. Mulligan, MD
University of Washington Medical Center
11:15 a.m. – 11:50 p.m.   Optimizing Hemodynamic Support: Are We Aiming for the Right Targets? Post-operative Monitoring/Related Complications
Nevin M. Katz, MD
Washington Institute of Thoracic & CV Surgery
12:00 p.m. – 1:30 p.m.   LUNCHEON SYMPOSIUM
Room 201, Metro Toronto Convention Centre

Hemodynamic Simulation Interactive Session

Chairs:
Nevin M. Katz, MD
Washington Institute of Thoracic & CV Surgery

John Frazier, RN, RRT
Edwards Lifescience, Critical Care
1:30 p.m. – 1:55 p.m.   Infection Prophylaxis and Prevention
Marin H. Kollef, MD
Washington University School of Medicine
1:55 p.m. – 2:20 p.m.   Clinical Use of the Artificial Lung
Joseph B. Zwischenberger, MD
University of Kentucky
2:20 p.m. – 2:45 p.m. Support for Acute Renal Dysfunction/Failure
Andrew D. Shaw, MD
Duke University
2:45 p.m. – 3:10 p.m.   Special Considerations for Aortic Surgery, Hybrid Procedures and TEVARs
Joseph E. Bavaria, MD
University of Pennsylvania
3:10 p.m. – 3:30 p.m.   BREAK
3:30 p.m. – 3:55 p.m.   Bleeding and Management of Coagulopathy
Jerrold Levy, MD
Emory University
3:55 p.m. – 4:20 p.m.   Nutritional Support and its Impact
Aaron M. Cheng, MD
Harborview Medical Center
4:20 p.m. – 4:45 p.m.   Assessment and Management of Neurologic Complications After Cardiac and Aortic Surgery
Joseph S. Coselli, MD
Texas Heart Institute/Baylor College of Medicine
4:45 p.m. – 5:00 p.m.   DISCUSSION
5:00 p.m.   ADJOURN TO WELCOME RECEPTION
Exhibit Hall A & B
 
3:00 p.m. - 5:00 p.m.   13th Annual C. Walton Lillehei Resident Forum
Room 206C, Metro Toronto Convention Centre

Chairs:
John S. Ikonomidis, MD
Medical University of South Carolina

Glen S. Van Arsdell, MD
Hospital for Sick Children

(7 minutes presentation, 8 minutes discussion)
    L1. BRCA1 is a Novel Regulator of Cardiac Function via Altering Myocardial Substrate Utilization and Mitochondrial Bioenergetics
Bobby Yanagawa, Praphulla Shukla, Krishna K. Singh, Hwee Teoh, Subodh Verma
Division of Cardiac Surgery, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada.

L2. AP2 Nucleolar Localization Predicts Poor Survival After Lung Cancer Resection in Stage I Patients
Min P. Kim1, Ying Chen2, Adriana Lopez3, Ignacio Wistuba2, Lin Ji1, Jack A. Roth1, Ruth L. Katz2
1. Thoracic and Cardiovascular Surgery, MD Anderson Cancer Center, Houston, TX; 2. Pathology, MD Anderson Cancer Center, Houston, TX;  3. Biostatistics, MD Anderson Cancer Center, Houston, TX

L3. Size and Polymer-Dependent Intranodal Localization of Methacrylate Nanoparticles
Onkar Khullar1, Kimberly Ann V. Zubris2, Aaron P. Griset2, John V. Frangioni3, Mark W. Grinstaff2, Yolonda L. Colson1
1. Division of Thoracic Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; 2. Departments of Biomedical Engineering and Chemistry, Boston University, Boston, MA; 3. Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA

L4. Dabigatran is Effective for Thromboprophylaxis of Mechanical Heart Valves
Stephen H. McKellar1, Stuart Abel1, Christopher Camp1, Mark Ereth2, Hartzell V. Schaff1
1. Cardiovascular Surgery, Mayo Clinic, Rochester, MN;
2. Anesthesia, Mayo Clinic, Rochester, MN

L5. Safe Efficient and Durable Transduction of Human and Canine Saphenous Vein Grafts Using a Modified Adeno Associated Viral Vector
Mani A. Daneshmand1, Nestor R. Villamizar1, Roberto J. Manson1, Thomas Mulhearn2, Christopher D. Kontos2, Carmelo A. Milano1, Dawn Bowles1
1. Surgery, Duke University Medical Center, Durham, NC;
2. Medicine, Division of Cardiology, Duke University Medical Center, Durham, NC

L6. Effects of Annuloplasty Ring Implantation on Regional Mitral Leaflet Tenting Area During Acute Myocardial Ischemia
Wolfgang Bothe1, Elizabeth H. Stephens1, John-Peder E. Kvitting1, Julia C. Swanson1, Neil B. Ingels2, D. Craig Miller1
1. Cardiothoracic Surgery, Stanford School of Medicine, Stanford, CA; 2. Laboratory of Cardiovascular Physiology and Biophysics, Research Institute of the Palo Alto Medical Foundation, Mountain View, CA

L7. Pro-Inflammatory Role of A2B Adenosine Receptor in Lung Ischemia-Reperfusion Injury
Farshad Anvari1, Ashish K. Sharma1, Lucas G. Fernandez1, Katya Ravid2, Irving L. Kron1, Victor E. Laubach1
1. Surgery, University of Virginia, Charlottesville, VA;
2. Biochemistry, Boston University School of Medicine, Boston, MA

L8. Effects of Nonselective COX and Selective COX-2 Inhibition on Collateral Development in the Heart
Michael P. Robich1, Louis M. Chu1, Jun Feng1, Cesario Bianchi1, Roger J. Laham2, Michael A. Coady3, Frank W. Sellke3
1. Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA; 2. Cardiology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA; 3. Surgery, Warren Alpert Medical School, Brown University, Providence, RI
5:00 p.m.   ADJOURN TO WELCOME RECEPTION
Exhibit Hall A & B


< 2010 Preliminary Program Index
Policies | Find a Surgeon | About | Contact
We Model Excellence
 Follow AATS on Facebook
Copyright © American Association for Thoracic Surgery. All rights reserved.
Read the Privacy Policy.
IMPORTANT REMINDER: The preceding information is intended only to provide
general guidance and not as a definitive basis for diagnosis or treatment in any particular case.
It is very important that you consult a doctor about any specific medical problem or question.